Cochrane Evidence Synthesis and Methods ►

Brexanolone and related neurosteroid GABA(A) positive allosteric modulators for postnatal depression

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To assess the effectiveness and safety of brexanolone and related neurosteroid GABA_A positive allosteric modulators in comparison with any other treatment (pharmacological, psychological, or psychosocial), placebo, or treatment as usual for postnatal depression (PND).

This is a protocol.

Published:

19 May 2021

Authors:

Wilson CA, Robertson L, Brown JV, Ayre K, Khalifeh H

See the full Review on

the Cochrane Library

►

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Wilson CA, Robertson L, Brown JV, Ayre K, Khalifeh H. Brexanolone and related neurosteroid GABA(A) positive allosteric modulators for postnatal depression (Protocol). Cochrane Database of Systematic Reviews 2021, Issue 5. Art. No.: CD014624. DOI: 10.1002/14651858.CD014624.